Johnson & Johnson reported $24.6 billion in sales for the fourth quarter of 2025, up 9.1% from the previous year. On an earnings call with investors, the company's CEO sang the praises of the company's cardiovascular health division.
The diet, named after the traditional eating habits of Greece and Italy, is already known for its benefits to the general public. Its impact on heart patients, however, was less clear.
Mount Sinai Hospital in New York is now using AI-powered virtual agents to call some patients before cath lab procedures. The move was designed to help nurses focus more on patient care and reduce their risk of burnout.
Extravascular ICDs were developed to avoid complications such as vascular injuries, lead fractures and lead infections. Although rare, these issues can cause serious, life-threatening complications for patients.
Medical societies representing all three specialties issued a joint statement Jan. 21, criticizing studies claiming such scans pose risk of potential patient harm.
The Healthcare Leadership Council—a forum for C-suite leaders across different industries—recently released the results of a new survey of its members.
The CGuard Prime carotid stent system from InspireMD was approved by the FDA in 2025. These data confirm the device's ability to reduce a patient's stroke risk during treatment.
SIR, AdvaMed, Philips, Abbott and others in the Office-Based Facility Association contend more must be done to reverse these trends and protect private practices.
Just because a healthcare AI product gets loudly promoted doesn’t mean its claims are bogus. The salient question is whether or not it performs as well in a clinical setting as it did in a research lab—or in a marketer’s mind.
Johnson & Johnson reported $24.6 billion in sales for the fourth quarter of 2025, up 9.1% from the previous year. On an earnings call with investors, the company's CEO sang the praises of the company's cardiovascular health division.
